Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v) Eye Drop
Therapeutic Category
Ophthalmology, Antibiotic, Analgesics, Anti-Inflammatories
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹105/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ketorine M Eye Drop contains Ketorolac (0.5% w/v), a non-steroidal anti-inflammatory drug (NSAID), and Moxifloxacin (0.5% w/v), a broad-spectrum fluoroquinolone antibiotic. This combination offers both anti-inflammatory and antibacterial actions, making it effective in reducing inflammation and treating or preventing eye infections.
It helps in the management of postoperative inflammation, allergic conjunctivitis, and bacterial eye infections, especially after eye surgeries or injuries.
May cause mild burning or stinging on application. Rarely, blurred vision, eye discomfort, or allergic reactions may occur.
Indicated for patients with eye inflammation and risk of or presence of bacterial infection, such as post-surgical care, conjunctivitis, or ocular trauma. Use under medical supervision.
Use only under the supervision of an eye care professional. Avoid touching the dropper tip to any surface or the eye. Remove contact lenses before use unless advised otherwise. Complete the prescribed course to prevent resistance.
Store below 25°C in a cool, dry place, away from direct sunlight. Keep out of reach of children. Discard after the recommended duration or as advised.
Composition : Sodium Carboxymethylcellulose I.P. 0.5% w/v + Oxychloro Complex 0.0075% v/v (As Perservatives) + Sterile Aqueous Base Eye Drop
Composition : Timolol (5mg) + Brimonidine (2mg) Eye Drop
Composition : Timolol (0.5% w/v) Eye Drop
Composition : Tobramycin (0.3% w/v) + Fluorometholone (0.1% w/v)
Composition : Loteprednol etabonate (0.5% w/v) + Tobramycin (0.3% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the ophthalmology and ENT infection-inflammation segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on eye, ear, and anti-infective portfolios.
Medical distributors and agencies can benefit from consistent demand for management of bacterial eye infections, conjunctivitis, ear infections with inflammation, redness, pain, and post-infection irritation. Moxifloxacin 0.5% is a broad-spectrum antibiotic effective against bacterial infections Ketorolac 0.5% is an NSAID that reduces pain, redness, and inflammation This combination strengthens a reliable dual-action anti-infective + anti-inflammatory ophthalmic and ENT portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ketorolac + Moxifloxacin Eye & Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong ophthalmologist and ENT prescriptions, high infection-season demand, hospital and clinic usage, reliable supply chain support, and good margins in anti-infective eye and ear medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.